ArticleBMC public health2026
Depressive symptom profiles across pregnant, postpartum, and nonperipartum women: measurement invariance and differential item functioning analyses of 2005-2021 NHANES data.
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe DSM-5-TR classifies peripartum depression as symptomatically indistinguishable from major depressive disorder (MDD). However, evidence suggests that depressive symptom profiles may differ among pregnant, postpartum, and nonperipartum (NPP) women. This study used 2005-2021 National Health and Nutrition Examination Survey data to evaluate Patient Health Questionnaire-9 (PHQ-9) depressive symptoms and assessed measurement equivalence across these groups.
methodsMeasurement invariance (MI) and differential item functioning (DIF) analyses included 632 pregnant, 385 postpartum, and 6,503 NPP women (aged 15-49 years). After confirming the PHQ-9 factor structure, we evaluated MI using multigroup confirmatory factor analysis (MGCFA) and assessed DIF using ordinal logistic regression and item response theory. In MGCFA, model changes supported invariance (measurement equivalence between groups) if ΔCFI ≥ -0.010 together with ΔRMSEA ≤ 0.015 and ΔSRMR ≤ 0.030 for metric invariance and ΔCFI ≥ -0.010 together with ΔRMSEA ≤ 0.015 and ΔSRMR ≤ 0.015 for scalar and strict invariance. DIF, defined as differential item responses between groups, was statistically significant at p < 0.01 (likelihood-ratio χ
resultsA two-factor PHQ-9 model was used. The cognitive-affective factor included anhedonia, depressed mood, guilt/worthlessness, concentration difficulty, psychomotor changes, and suicidal ideation. The somatic factor included sleep disturbance, fatigue, and appetite changes. MGCFA supported metric (ΔCFI = -0.0005, ΔRMSEA = -0.0001, ΔSRMR = 0.0027), scalar (ΔCFI = 0.0004 and ΔSRMR = -0.0024), and strict invariance (ΔCFI and ΔSRMR < 0.0001). Statistically significant DIF emerged between pregnant and NPP women (guilt/worthlessness, psychomotor changes, fatigue, and appetite changes), postpartum and NPP women (sleep disturbance and fatigue), and pregnant and postpartum women (sleep disturbance). However, all statistically significant DIF effects were modest and of minimal clinical relevance (total DIF pseudo-R
conclusionThe PHQ-9 assesses depressive symptoms equivalently in pregnant, postpartum, and NPP women, allowing meaningful comparisons across groups. At equivalent depression severity, differences in PHQ-9 item responses across these groups are modest and of minimal clinical relevance. The absence of symptom bias does not support a distinction between peripartum depression and DSM-5-TR MDD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.